Search research articles
Contact Us
Filters
Showing results (341-350 of 361) with videos related to
Page
of 37
Sort By:
Nature Communications
|
November 18, 2024
Generation of chimeric antigen receptor T cells targeting p95HER2 in solid tumors
Macarena Román Alonso, Ariadna Grinyó-Escuer, Santiago Duro-Sánchez, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 11, 2016
A Novel Carcinoembryonic Antigen T-Cell Bispecific Antibody (CEA TCB) for the Treatment of Solid Tumors
Marina Bacac, Tanja Fauti, Johannes Sam, et al.
Haematologica
|
April 3, 2016
Salvage therapy with high-dose cytarabine and mitoxantrone in combination with all-trans retinoic acid and gemtuzumab ozogamicin in acute myeloid leukemia refractory to first induction therapy
Marie-Luise Hütter-Krönke, Axel Benner, Konstanze Döhner, et al.
Archives of General Psychiatry
|
July 8, 2009
Genome-wide association study of alcohol dependence
Jens Treutlein, Sven Cichon, Monika Ridinger, et al.
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry
|
May 12, 2021
Tools for optimising pharmacotherapy in psychiatry (therapeutic drug monitoring, molecular brain imaging and pharmacogenetic tests): focus on antidepressants
C B Eap, G Gründer, P Baumann, et al.
Oncoimmunology
|
April 14, 2017
Cergutuzumab amunaleukin (CEA-IL2v), a CEA-targeted IL-2 variant-based immunocytokine for combination cancer immunotherapy: Overcoming limitations of aldesleukin and conventional IL-2-based immunocytokines
Christian Klein, Inja Waldhauer, Valeria G Nicolini, et al.
Mabs
|
May 11, 2021
Simlukafusp alfa (FAP-IL2v) immunocytokine is a versatile combination partner for cancer immunotherapy
Inja Waldhauer, Valeria Gonzalez-Nicolini, Anne Freimoser-Grundschober, et al.
American Journal of Human Genetics
|
February 7, 2008
Structural variation of chromosomes in autism spectrum disorder
Christian R Marshall, Abdul Noor, John B Vincent, et al.
Current Sports Medicine Reports
|
March 11, 2015
Ice Hockey Summit II: zero tolerance for head hits and fighting
Aynsley M Smith, Michael J Stuart, David W Dodick, et al.
Clinical Journal of Sport Medicine : Official Journal of the Canadian Academy of Sport Medicine
|
April 14, 2015
Ice Hockey Summit II: zero tolerance for head hits and fighting
Aynsley M Smith, Michael J Stuart, David W Dodick, et al.
Page
of 37
Search research articles
Search
Showing results (341-350 of 361) with videos related to
Sort By:
Page
of 37
Nature Communications
|
November 18, 2024
Generation of chimeric antigen receptor T cells targeting p95HER2 in solid tumors
Macarena Román Alonso, Ariadna Grinyó-Escuer, Santiago Duro-Sánchez, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 11, 2016
A Novel Carcinoembryonic Antigen T-Cell Bispecific Antibody (CEA TCB) for the Treatment of Solid Tumors
Marina Bacac, Tanja Fauti, Johannes Sam, et al.
Haematologica
|
April 3, 2016
Salvage therapy with high-dose cytarabine and mitoxantrone in combination with all-trans retinoic acid and gemtuzumab ozogamicin in acute myeloid leukemia refractory to first induction therapy
Marie-Luise Hütter-Krönke, Axel Benner, Konstanze Döhner, et al.
Archives of General Psychiatry
|
July 8, 2009
Genome-wide association study of alcohol dependence
Jens Treutlein, Sven Cichon, Monika Ridinger, et al.
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry
|
May 12, 2021
Tools for optimising pharmacotherapy in psychiatry (therapeutic drug monitoring, molecular brain imaging and pharmacogenetic tests): focus on antidepressants
C B Eap, G Gründer, P Baumann, et al.
Oncoimmunology
|
April 14, 2017
Cergutuzumab amunaleukin (CEA-IL2v), a CEA-targeted IL-2 variant-based immunocytokine for combination cancer immunotherapy: Overcoming limitations of aldesleukin and conventional IL-2-based immunocytokines
Christian Klein, Inja Waldhauer, Valeria G Nicolini, et al.
Mabs
|
May 11, 2021
Simlukafusp alfa (FAP-IL2v) immunocytokine is a versatile combination partner for cancer immunotherapy
Inja Waldhauer, Valeria Gonzalez-Nicolini, Anne Freimoser-Grundschober, et al.
American Journal of Human Genetics
|
February 7, 2008
Structural variation of chromosomes in autism spectrum disorder
Christian R Marshall, Abdul Noor, John B Vincent, et al.
Current Sports Medicine Reports
|
March 11, 2015
Ice Hockey Summit II: zero tolerance for head hits and fighting
Aynsley M Smith, Michael J Stuart, David W Dodick, et al.
Clinical Journal of Sport Medicine : Official Journal of the Canadian Academy of Sport Medicine
|
April 14, 2015
Ice Hockey Summit II: zero tolerance for head hits and fighting
Aynsley M Smith, Michael J Stuart, David W Dodick, et al.
Page
of 37